In summary and irrespective of the pathway which is activated, increased activation of the NLRP3 inflammasome leads to the regulation and execution of inflammatory responses, a process that becomes dysregulated in diseases including diabetic nephropathy (Shen et al., 2022). This evidence concerns the gene NLRP3 and diabetic kidney disease.